The Bristol Royal Infirmary, also known as the BRI, is a large teaching hospital situated in the centre of Bristol, England. It has links with the nearby University of Bristol and the Faculty of Health and Social Care at the University of the West of England, also in Bristol.The BRI is one of nine hospitals operated by the University Hospitals Bristol and Weston NHS Foundation Trust. It is located on the same site the Bristol Royal Hospital for Children, Bristol Haematology and Oncology Centre, and Bristol Heart Institute (BHI). The Bristol Haematology and Oncology Centre has 49 beds and the Bristol Heart Institute has 107, which are not included in the main hospital’s total.
Background:Clinical triage requires integrating multiple information sources to identify patients at risk of deterioration. Tools capturing global health assessments beyond disease-specific scores are being developed using either bottom-up aggregation of simple indicators or top-down machine learning from large datasets. Their alignment with expert clinical judgment remains poorly characterized. Objective:This study evaluates 2 latent health measurement approaches: Frailty Index-laboratory, a transparent bottom-up tool aggregating laboratory abnormalities via deficit accumulation theory, and ETHOS-ARES (Enhanced Transformer for Health Outcome Simulation-Adaptive Risk Estimation System), a transformer-based foundation model generating multidimensional patient representations from electronic health records. We assess whether each tool's severity rankings align with clinical consensus and whether they offer utility in triage decisions. Methods:In this 3-phase mixed methods study, at least 30 clinicians across hospital specialties reviewed 20 emergency department presentations derived from Medical Information Mart for Intensive Care IV-Emergency Department. Phase 1 compared unaided clinician severity and urgency judgments against model outputs using Spearman rank correlation, with a Turing-inspired indistinguishability test assessing whether model rankings fell within the distribution of clinician assessments. Phase 2 allocated clinicians to receive Frailty Index-laboratory or ETHOS-ARES outputs, measuring anchoring effects via within-person pre-post comparisons and exploring clinical utility through semistructured interviews analyzed using the Framework Method. Results:Ethics approval was granted in June 2025 (KCL Research Ethics Office; MRSP-24/25-48707). Recruitment began in October 2025 (32 clinicians recruited as of manuscript submission), with data collection expected to be completed in January 2026 and analysis planned for March or April 2026. Conclusions:This study will quantify model-clinician agreement, measure anchoring effects, and generate qualitative insights on utility, trust, and adoption. The findings will inform the implementation of latent health measurement tools in clinical practice and provide a framework for the early-stage evaluation of artificial intelligence-based clinical decision support systems.
Objective To study the clinical and radiological characteristics of stroke due to intracerebral haemorrhage (ICH) in people living with HIV (PLWH) in Malawi. Methods Using a cross-sectional design, we compared the clinical and radiological characteristics of ICH in PLWH and HIV negative patients. We rated ICH location as deep, or lobar, using the Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS), and radiological features, including periventricular and deep white matter hyperintensities (PVWM and DWM) using the Fazekas score. Reviewers were blinded to HIV status. We compared findings using the t-test, Mann-Whitney U or Fisher exact test. Results We included 39 participants with ICH (10 PLWH; 29 HIV-negative). The median age was 60 (IQR 48–68); 22 (56%) were female. Among the HIV-positive ICH-group, the median (IQR) CD4 count was 364 cells/mm 3 (164,411), and 7 (70%) were naïve to HIV treatment. Compared with HIV-negative controls, HIV-positive patients were younger (median (IQR) 49.5 (35, 60) v 62(54,69), p = 0.049), and less frequently hypertensive (80% v 90%, p = 0.431). HIV-positive patients with ICH often had lobar haematoma location (40% v 0, p = 0.000, and p = 0.002 after controlling for age). White matter hyperintensities (PVWM 77% vs 79%, p = 0.547; DWM 60% vs 69%, p = 0.604) were prevalent and comparable between the groups despite the age disparity. Conclusions In PLWH and ICH-Stroke, we found a younger age and more frequent lobar location, signifying different underlying mechanisms compared to HIV-negative controls. Moreover, hypertension and cerebral small vessel disease markers were common in both groups, suggesting that better treatment of hypertension could reduce the burden of stroke due to ICH regardless of HIV status.
Background: Daibetes Mellitus (DM) is one of the most prevalent chronic conditions worldwide, and orthopaedic patients with poorly controlled DM often have poorer functional outcomes and increased complication rates. It is crucial to understand how to identify and mitigate as much risk as is feasible in this population when considering foot and ankle surgery. Foot and ankle surgery is particularly fraught with difficulty given the predilection diabetes has for the foot in the development of pathologies and complications. Methods: PubMed, Embase, MEDLINE, Ovid, Cochrane Library, and Trip medical databases were searched to identify studies concerning postoperative complications and their relationship to pre-operative HbA 1c measurements following foot and ankle surgeries. Patient characteristic data; HbA 1c data; and post-operative complication data was collected. Surgeries for amputations and existing infections were excluded. Results: A total of 2506 articles were highlighted on literature search. Twenty-nine full-text articles were accessible and read for inclusion. Of these, thirteen full-text articles were included in the review. Six studies showed a correlation between elevated HbA 1c and surgical site infection development; three studies found no significant link. No clear overall correlation could be found between higher HbA 1c and bone healing complications. Data suggested that peripheral neuropathy (PN) and peripheral vascular disease (PVD) may be correlated to development of complications . Conclusion: No clear HbA 1c threshold could be identified as an evidence-based cut-off value. Data from included studies suggested a relationship between elevated HbA 1c and surgical site infection development, although because of data heterogeneity these results are hypothesis-generating only and require more standardised reporting for analysis. Conclusions could not be drawn for bone healing complications. The presence of PVD and PN emerged as potentially stronger predictors than HbA 1c in a small number of studies; this hypothesis-generating observation requires further investigation to assess its true impact on development of complications and poor post-operative outcomes.
Abstract Objectives McCune–Albright syndrome (MAS) is a rare mosaic disorder caused by postzygotic activating variants in GNAS , resulting in constitutive activation of stimulatory G protein alpha subunit (Gsα) signalling. The phenotype classically includes fibrous dysplasia, café-au-lait macules and hyperfunctioning endocrinopathies, but the clinical spectrum extends beyond this triad. We describe four paediatric cases and review the current literature, with emphasis on the diagnostic challenges of mosaicism, endocrine morbidity and evolving treatment. Case presentation The four cases comprise a boy with polyostotic fibrous dysplasia, hyperthyroidism and Sertoli-cell hyperplasia; a girl with early fractures, peripheral precocious puberty, suspected phosphate wasting and craniofacial fibrous dysplasia; an adolescent with segmental pigmentation, pain and MRI-confirmed fibrous dysplasia after negative blood and skin testing; and a girl with very early gonadotropin-independent precocious puberty, transient hepatobiliary abnormalities and positive GNAS testing from a café-au-lait macule but no MRI evidence of fibrous dysplasia. Conclusions MAS is a dynamic multisystem mosaic disorder in which manifestations may emerge at different ages and in no fixed order. Negative blood testing does not exclude the diagnosis. Longitudinal endocrine, skeletal, ophthalmological and multidisciplinary surveillance is essential, and treatment should be directed at both endocrine control and preservation of skeletal function.